Table 12. Mutation types and basic information of EGFR gene mutations.
| Clinicopathological features | Classification | Cases | Rate (%) |
|---|---|---|---|
| Gender | Male | 25 | 51.02 |
| Female | 24 | 48.98 | |
| Age | ≥60 | 22 | 44.90 |
| <60 | 27 | 55.10 | |
| TNM staging | IV | 45 | 91.84 |
| Non-IV | 4 | 8.16 | |
| Smoking history | Yes | 22 | 44.90 |
| No | 27 | 55.10 | |
| Pathological type | ADC | 47 | 95.92 |
| SCC | 2 | 4.08 | |
| EGFR gene mutations | Exon 2 | 1 | 1.35 |
| Exon 4 | 1 | 1.35 | |
| Exon 6 | 1 | 1.35 | |
| Exon 18 | 1 | 1.35 | |
| Exon 19 | 25 | 33.78 | |
| Exon 20 | 12 | 16.22 | |
| Exon 21 | 19 | 25.68 | |
| Exon 22 | 1 | 1.35 | |
| EGFR amplification | 13 | 17.57 |
ADC, adenocarcinoma; SCC, squamous cell carcinoma.